Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Pauleikhoff

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|July 24, 2002
Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implicationsD Pauleikhoff, D Löffert, G Spital, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|May 5, 2005
[Association between classic cardiovascular risk factors and age-related maculopathy (ARM). Results of the baseline examination of the Münster Aging and Retina Study (MARS)]B Dasch, A Fuhs, A Meister, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|November 18, 2003
Macular pigment: quantitative analysis on autofluorescence imagesM Trieschmann, G Spital, A Lommatzsch, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|September 11, 2014
[Therapeutic approaches for macular telangiectasia type 2: status quo and perspectives]F G Holz, T F C Heeren, E Krüger, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|September 11, 2014
[Morphological characteristics in macular telangiectasia type 2]P Charbel Issa, T F C Heeren, E Krüger, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|August 5, 2021
[Real-life experiences with Brolucizumab in recalcitrant neovascular age-related macular degeneration]Marius Book, M Ziegler, K Rothaus, et al.
Ophthalmic Genetics|March 23, 2001
EFEMP1 is not associated with sporadic early onset drusenC G Sauer, K White, U Kellner, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|September 19, 2013
[Tear in retinal pigment epithelium under anti-VEGF therapy for exudative age-related macular degeneration : function recovery under intensive therapy]S Bartels, A Barrelmann, B Book, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|June 21, 2018
[Pro re nata anti-VEGF treatment results for neovascular age-related macular degeneration in routine clinical treatment: comparison of single with triple injections]M W M Wintergerst, P P Larsen, B Heimes, et al.
Klinische Monatsblatter Fur Augenheilkunde|May 3, 2014
[Initial clinical experience in the treatment of vitreomacular traction and macular holes with ocriplasmin]A P Lommatzsch, M Gutfleisch, M Dietzel, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|July 24, 2002
Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implicationsD Pauleikhoff, D Löffert, G Spital, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|May 5, 2005
[Association between classic cardiovascular risk factors and age-related maculopathy (ARM). Results of the baseline examination of the Münster Aging and Retina Study (MARS)]B Dasch, A Fuhs, A Meister, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|November 18, 2003
Macular pigment: quantitative analysis on autofluorescence imagesM Trieschmann, G Spital, A Lommatzsch, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|September 11, 2014
[Therapeutic approaches for macular telangiectasia type 2: status quo and perspectives]F G Holz, T F C Heeren, E Krüger, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|September 11, 2014
[Morphological characteristics in macular telangiectasia type 2]P Charbel Issa, T F C Heeren, E Krüger, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|August 5, 2021
[Real-life experiences with Brolucizumab in recalcitrant neovascular age-related macular degeneration]Marius Book, M Ziegler, K Rothaus, et al.
Ophthalmic Genetics|March 23, 2001
EFEMP1 is not associated with sporadic early onset drusenC G Sauer, K White, U Kellner, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|September 19, 2013
[Tear in retinal pigment epithelium under anti-VEGF therapy for exudative age-related macular degeneration : function recovery under intensive therapy]S Bartels, A Barrelmann, B Book, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|June 21, 2018
[Pro re nata anti-VEGF treatment results for neovascular age-related macular degeneration in routine clinical treatment: comparison of single with triple injections]M W M Wintergerst, P P Larsen, B Heimes, et al.
Klinische Monatsblatter Fur Augenheilkunde|May 3, 2014
[Initial clinical experience in the treatment of vitreomacular traction and macular holes with ocriplasmin]A P Lommatzsch, M Gutfleisch, M Dietzel, et al.
Pageof 12